...
首页> 外文期刊>The American journal of pathology. >Epigenetic Down-Regulation of the Tumor Suppressor Gene PRDM1/Blimp-1 in Diffuse Large B Cell Lymphomas: A Potential Role of the MicroRNA Let-7
【24h】

Epigenetic Down-Regulation of the Tumor Suppressor Gene PRDM1/Blimp-1 in Diffuse Large B Cell Lymphomas: A Potential Role of the MicroRNA Let-7

机译:弥漫性大B细胞淋巴瘤中的肿瘤抑制基因PRDM1 / Blimp-1的表观遗传下调:MicroRNA Let-7的潜在作用。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

PRDM1/Blimp-1, a master regulator for B cell terminal differentiation, is a putative tumor suppressor in diffuse large B cell lymphomas (DLBCL). Inactivating mutations of PRDM1 have been previously identified in a subset of nongerminal center B cell-like (GCB) DLBCL. We investigated the presence of alternative mechanisms of down-regulating PRDM1 in a cohort of 25 primary DLBCL and six DLBCL cell lines. While some DLBCL, predominantly the GCB-type, showed low levels of both PRDM1[alpha] mRNA and protein, presumably as a result of direct transcription repression, discordant expressions between the two were identified in a subset of DLBCL without PRDM1 mutations, the primarily non-GCB type, consistent with translational down-regulation. This subset of DLBCL exhibits relatively high PRDM1[alpha] mRNA levels but low levels of PRDM1. Data obtained from expression analysis, luciferase reporter assays, and transfection experiments support a role of targeting of PRDM1 by microRNA let-7 family in mediating this down-regulation. Let-7, in particular let-7b, is overexpressed in DLBCL relative to normal GCB cells, suggesting that it is deregulated. Thus, abnormal epigenetic down-regulation of PRDM1 by let-7 and other microRNAs may represent an alternative mechanism of reducing normal PRDM1 function in a subset of DLBCL with relatively high PRDM1[alpha] mRNA expression and unmutated PRDM1. These findings provide further evidence for an important role of impairment of terminal B cell differentiation in DLBCL pathogenesis.
机译:PRDM1 / Blimp-1是B细胞末端分化的主要调节剂,是弥漫性大B细胞淋巴瘤(DLBCL)中的一种公认的肿瘤抑制因子。 PRDM1的失活突变先前已在非生发中心B细胞样(GCB)DLBCL的子集中进行了鉴定。我们调查了25个原发性DLBCL和6个DLBCL细胞系中下调PRDM1的其他机制的存在。尽管一些DLBCL(主要是GCB型)显示出低水平的PRDM1αmRNA和蛋白质,可能是直接转录抑制的结果,但在没有PRDM1突变的DLBCL子集中鉴定了两者之间的不一致表达,主要是非GCB类型,与翻译下调一致。 DLBCL的这个子集表现出相对较高的PRDM1αmRNA水平,但是较低的PRDM1水平。从表达分析,荧光素酶报告基因分析和转染实验中获得的数据支持microRNA let-7家族靶向PRDM1在介导这种下调中的作用。相对于正常的GCB细胞,let-7,尤其是let-7b在DLBCL中过表达,表明它被失调了。因此,let-7和其他微小RNA对PRDM1的异常表观遗传下调可能代表了降低具有相对高的PRDM1αmRNA表达和未突变的PRDM1的DLBCL子集中正常PRDM1功能的另一种机制。这些发现提供了进一步的证据,证明了终末B细胞分化受损在DLBCL发病机理中的重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号